Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
US Army
Federal Trade Commission
Medtronic
Harvard Business School
Johnson and Johnson
Dow
Queensland Health
Chubb

Generated: August 21, 2017

DrugPatentWatch Database Preview

PHOSLO GELCAPS Drug Profile

« Back to Dashboard

What is the patent landscape for Phoslo Gelcaps, and what generic Phoslo Gelcaps alternatives are available?

Phoslo Gelcaps is a drug marketed by Fresenius Medcl and is included in one NDA. There are two patents protecting this drug.

The generic ingredient in PHOSLO GELCAPS is calcium acetate. There are two hundred and sixty-eight drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.

Summary for Tradename: PHOSLO GELCAPS

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list29
Clinical Trials: see list11
Patent Applications: see list23
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PHOSLO GELCAPS at DailyMed

Pharmacology for Tradename: PHOSLO GELCAPS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Medcl
PHOSLO GELCAPS
calcium acetate
CAPSULE;ORAL021160-003Apr 2, 2001ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Fresenius Medcl
PHOSLO GELCAPS
calcium acetate
CAPSULE;ORAL021160-003Apr 2, 2001ABRXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PHOSLO GELCAPS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fresenius Medcl
PHOSLO GELCAPS
calcium acetate
CAPSULE;ORAL021160-003Apr 2, 2001► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Merck
Colorcon
US Department of Justice
Daiichi Sankyo
Argus Health
Teva
Mallinckrodt
Cerilliant
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot